{"doi":"10.1016/j.ejca.2022.08.024","title":"Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study","abstract":"BACKGROUND: IMbrave150 has established the superiority of atezolizumab plus bevacizumab over sorafenib in patients with unresectable hepatocellular carcinoma (HCC). METHODS: We generated a prospectively maintained database including patients treated with atezolizumab plus bevacizumab for unresectable HCC across Europe, Asia and USA. Clinico-pathologic characteristics were assessed for their prognostic influence on overall survival (OS) and progression-free survival (PFS) in univariable and multivariate analyses. Overall response rate by RECIST v1.1 and treatment-related adverse events (TRAEs) per CTCAE v.5.0 were reported. RESULTS: Out of 433 patients, 296 Child-Pugh A and ECOG performance status01 patients received atezolizumab plus bevacizumab in first line and were included. Patients were mostly male (82.7%), cirrhotic (75%) with history of viral hepatitis (65.9%). Overall, 68.9% had Barcelona Clinic Liver Cancer C-stage HCC with portal vein tumour thrombosis (PVTT, 35%) and extrahepatic spread (EHS, 51.7%). After a median follow-up of 10.0 months (95% confidence interval (CI): 9.4-10.4), median OS and PFS were 15.7 (95% CI: 14.5-NE) and 6.9 months (95% CI: 6.1-8.3), respectively. In the response-evaluable patients (n = 273), overall response rate was 30.8%. Overall, 221 patients (74.6%) developed TRAEs, with 70 (23.6%) reporting grade 3 or higher TRAEs; 25 (8.4%) patients had bleeding events. OS was independently associated with baseline Albumin-bilirubin (ALBI) grade and PVTT. Shorter PFS was associated with AFP≥ 400 ng/ml, worse ALBI and presence of EHS. CONCLUSION: This global observational study confirms the reproducible safety and efficacy of atezolizumab plus bevacizumab in routine clinical practice. Within Child-Pugh-A criteria, the presence of PVTT and higher ALBI grade identify patients with poorer survival.","journal":"European Journal of Cancer","year":2022,"id":233918,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":112,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.7192,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":848450,"name":"Jaekyung Cheon","orcid":"0000-0001-8439-1739","position":1,"is_corresponding":false},{"id":848451,"name":"Antonio D’Alessio","orcid":"0000-0002-9164-3671","position":2,"is_corresponding":false},{"id":848452,"name":"Naoshi Nishida","orcid":"0000-0002-9111-5668","position":3,"is_corresponding":false},{"id":848453,"name":"Celina Ang","orcid":"0009-0006-1249-9250","position":4,"is_corresponding":false},{"id":104257,"name":"Thomas U. Marron","orcid":"0000-0001-5903-8191","position":5,"is_corresponding":false},{"id":848454,"name":"Linda Y. Wu","orcid":"0000-0002-5818-7678","position":6,"is_corresponding":false},{"id":848455,"name":"Anwaar Saeed","orcid":"0000-0001-8024-9401","position":7,"is_corresponding":false},{"id":848456,"name":"Brooke Wietharn","orcid":"0000-0002-7892-3679","position":8,"is_corresponding":false},{"id":848457,"name":"Antonella Cammarota","orcid":"0000-0001-9967-4694","position":9,"is_corresponding":false},{"id":848458,"name":"Tiziana Pressiani","orcid":"0000-0001-6919-1536","position":10,"is_corresponding":false},{"id":848459,"name":"Nicola Personeni","orcid":"0000-0002-7995-272X","position":11,"is_corresponding":false},{"id":848460,"name":"Matthias Pinter","orcid":"0000-0002-7260-532X","position":12,"is_corresponding":false},{"id":848461,"name":"Bernhard Scheiner","orcid":"0000-0002-4904-5133","position":13,"is_corresponding":false},{"id":848462,"name":"Lorenz Balcar","orcid":"0000-0002-6708-3061","position":14,"is_corresponding":false},{"id":848463,"name":"Andrea Napolitano","orcid":"0000-0002-7509-1555","position":15,"is_corresponding":false},{"id":457659,"name":"Yi‐Hsiang Huang","orcid":"0000-0001-5241-5425","position":16,"is_corresponding":false},{"id":435337,"name":"Samuel Phen","orcid":"0000-0002-9960-2102","position":17,"is_corresponding":false},{"id":564663,"name":"Abdul Rafeh Naqash","orcid":"0000-0001-7622-720X","position":18,"is_corresponding":false},{"id":848464,"name":"Caterina Vivaldi","orcid":"0000-0001-9307-2326","position":19,"is_corresponding":false},{"id":848465,"name":"Francesca Salani","orcid":"0000-0001-7749-8634","position":20,"is_corresponding":false},{"id":848466,"name":"Gianluca Masi","orcid":"0000-0001-8329-8989","position":21,"is_corresponding":false},{"id":848467,"name":"Dominik Bettinger","orcid":"0000-0002-8782-8729","position":22,"is_corresponding":false},{"id":848468,"name":"Arndt Vogel","orcid":"0000-0003-0560-5538","position":23,"is_corresponding":false},{"id":848469,"name":"Martin Schönlein","orcid":"0000-0002-1010-0975","position":24,"is_corresponding":false},{"id":231491,"name":"Johann von Felden","orcid":"0000-0003-2839-5174","position":25,"is_corresponding":false},{"id":848470,"name":"Kornelius Schulze","orcid":"0000-0001-7078-9260","position":26,"is_corresponding":false},{"id":848471,"name":"Henning Wege","orcid":"0000-0002-5924-796X","position":27,"is_corresponding":false},{"id":54190,"name":"Peter R. Galle","orcid":"0000-0001-8294-0992","position":28,"is_corresponding":false},{"id":54193,"name":"Masatoshi Kudo","orcid":"0000-0002-4102-3474","position":29,"is_corresponding":false},{"id":848472,"name":"Lorenza Rimassa","orcid":"0000-0001-9957-3615","position":30,"is_corresponding":false},{"id":106840,"name":"Amit G. Singal","orcid":"0000-0002-1172-3971","position":31,"is_corresponding":false},{"id":639050,"name":"Rohini Sharma","orcid":"0000-0003-2441-549X","position":32,"is_corresponding":false},{"id":321561,"name":"Alessio Cortellini","orcid":"0000-0002-1209-5735","position":33,"is_corresponding":false},{"id":848473,"name":"Vincent E. Gaillard","orcid":"0000-0002-1180-4958","position":34,"is_corresponding":false},{"id":848474,"name":"Hong Jae Chon","orcid":"0000-0002-6979-5812","position":35,"is_corresponding":false},{"id":627449,"name":"David J. Pinato","orcid":"0000-0002-3529-0103","position":36,"is_corresponding":false},{"id":848449,"name":"Claudia Angela Maria Fulgenzi","orcid":"0000-0002-5654-9225","position":0,"is_corresponding":true}],"reference_count":29,"raw_metadata":null,"created_at":"2026-07-19T00:21:31.237180Z","pmid":"36148739","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}